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Abstract
Traumatic brain injury (TBI) is one of the commonest presentations to emergency departments and is associated with seizures 
carrying different significance at different stages following injury. We describe the epidemiology of early and late seizures 
following TBI, the significance of intracranial haemorrhage of different types in the risk of later epilepsy and the gaps in 
current understanding of risk factors contributing to the risk of post-traumatic epilepsy (PTE). The delay from injury to 
epilepsy presents an opportunity to understand the mechanisms underlying changes in the brain and how they may reveal 
potential targets for anti-epileptogenic therapy. We review existing treatments, both medical and surgical and conclude that 
current research is not tailored to differentiate between PTE and other forms of focal epilepsy. Finally, we review the increas-
ing understanding of the frequency and significance of dissociative seizures following mild TBI.
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Introduction
Seizures were first described in relation to a “gaping wound 
of the head” in the Edwin Smith papyrus from Babylon, 
dated circa 1700 BC [1]. The Hippocratic physicians later 
recognised post-traumatic convulsions and their lateralisa-
tion opposite to the side of injury [2]. Through much of 
the next 2000 years, Galen’s philosophy of humours merged 
with spiritual explanations of epilepsy and it was not until 
the nineteenth century that understanding advanced to 
form the basis of current knowledge. In the UK, Gowers 
recognised the frequency of PTE and its male preponder-
ance [3], which was followed shortly first epilepsy surgery 
of the modern era, conducted on a patient with PTE [4]. 
Holmes identified epilepsy as a cortical disease and used his 
extensive experience of traumatic brain injuries from WWI 
to describe a range of seizure types arising from injuries 
to different cortical regions [5]. Epilepsy surgery over the 
next decades was dominated by the Montreal Group who 
described the macroscopic and microscopic appearance of 
traumatic lesions associated with epilepsy in both humans 
and animals [6]. The extent of the risk was highlighted by 
Jennett [7] who set the investigative parameters for epide-
miological studies which later investigators have followed 
in systematic attempts to delineate the risk factors for PTE 
[8, 9], but significant holes remain in our understanding. 
The better stratification of risk could potentially allow tar-
geted treatment as epilepsy management starts to include 
treatments which may be anti-epileptogenic as well as anti-
seizure. To date, the treatment of PTE has not been suf-
ficiently separated from other forms of focal epilepsy to be 
able to give specific data. We also highlight the increasing 
recognition that seizures after mild traumatic brain injury 
are commonly dissociative rather than epileptic.
Epidemiology
Over 2% of the population attend emergency departments 
in England and Wales each year with a head injury [10]. 
Between one-third and one half are children and one-fifth 
have a skull fracture or evidence of traumatic brain injury 
(TBI). Approximately 15% will require admission to hos-
pital. Seizures may be almost instantaneous “concussive” 
episodes; early seizures within 7 days of injury and late epi-
leptic seizures, beyond 7 days from injury.
Concussive seizures were originally described in Aus-
tralian football players [11]. They are convulsive and occur 
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within seconds of impact. Their semiology differs from 
tonic–clonic seizures and is postulated to contain elements 
of primitive reflexes [12]. They are believed to carry no risk 
of later epilepsy.
Early seizures were seen in 4.5% of a cohort of 1000 
unselected patients with head injury in Oxford [7] and were 
associated with skull fracture or intracranial haemorrhage. 
Lee and Lui found that early seizures occur after 2.4% of 
4232 head injuries, defined as mild, on the basis of clini-
cal criteria Glasgow Coma Score (GCS), but imaging in 
a significant proportion subsequently showed significant 
haemorrhage, putting patients into a more severe category 
[13]. Over 80% of seizures were tonic–clonic rather than 
focal. A recent, large study [14] has expanded knowledge 
of the frequency of early seizures. They identified risk fac-
tors in a 2 year cohort of all admissions with TBI amongst 
patients over age 18 years from the National Trauma Data 
Bank of the USA. Of 360,863 patients admitted, only 1559 
(0.4%) suffered early seizures. This is relatively few com-
pared to other studies but even this cohort had a mortality 
of 7%, reflecting an inherently more severe group than the 
totality of TBI patients, many of whom are never admitted 
to hospital. There was an over-representation of Afro-Car-
ibbean patients 20% v 12% for the population. A previous 
history of alcohol abuse was seen in 25% of those with early 
seizures versus 11% of those without, but intoxication at 
the time of admission was significantly less common 13% 
v 24%. Common comorbidities were all more frequent in 
those with seizures: smoking, obesity, hypertension or vas-
cular disease. Risk of seizure was 0.38% of 273,327 with 
mild TBI, defined as Glasgow coma score (GCS) 13–15; 
0.8% of 15,467 with moderate TBI (GCS 9–12) and 0.5% of 
54,545 with severe TBI (GCS < 9). That moderate TBI was 
much less common than severe TBI, perhaps raises ques-
tions around severity definitions. Subarachnoid and sub-
dural haemorrhage were associated with an increased risk 
but epidural and intraparenchymal haemorrhage were not. 
The vast majority of intraparenchymal haemorrhages were 
contusions, which seem to carry a low risk, whereas large 
intraparenchymal haemorrhages carry a much higher risk. 
Early seizures were associated with longer stay in intensive 
care, longer overall admissions a higher chance of discharge 
to a nursing facility rather than to home but no significant 
difference in mortality.
Studies have also looked at subclinical seizures, manifest 
on EEG monitoring. For example, in a study of 94 patients 
labelled as with moderate to severe TBI, Vespa found 21 suf-
fered seizures; five tonic–clonic; four with subtle motor phe-
nomena and the others purely electrographic. All six patients 
in status died, including one in whom there were no motor 
manifestations; four of these had a hypoxic insult superim-
posed on TBI [15]. Arndt et al. found that of children with 
TBI, subclinical seizures occurred in 16.1% of children 
undergoing monitoring and in 6.8% this was the only epilep-
tic manifestation. Subclinical status epilepticus was reported 
in 13.8% and any epileptic manifestation, whether clinical 
or subclinical was associated with a poorer outcome from 
TBI in this cohort [16]. A consensus statement has recom-
mended continuous EEG monitoring for a patients with a 
range of cerebral insults, including moderate to severe TBI, 
in whom there is a clinical suspicion of seizures, suggested 
by paroxysmal events of uncertain nature, altered or fluctu-
ating mental state or anaesthesia and paralysis which may 
mask seizures in a clinical context, where there is significant 
risk [17]. This counsel of excellence is difficult to achieve 
in many centres and truly large-scale studies are lacking.
In an epilepsy population, approximately 5% of incident 
cases and approximately 20% of prevalent cases may be due 
to previous TBI [18–20]. The overall incidence of epilepsy 
is lowest in adults from 25 to 65, having emerged from 
childhood and adolescence without epilepsy due to genetic, 
developmental or perinatal causes and not yet suffering high 
rates of cerebrovascular or degenerative disease. But this 
group, especially males, have a significant risk of cerebral 
trauma and on a background of low risk from other causes, 
proportionately, they have the highest incident risk of PTE. 
However, any given individual’s risk of developing seizures 
after similar trauma may in fact be higher in the very young 
or the elderly [21].
Those who have suffered penetrating brain injuries carry 
the highest risk; for example just over half of Vietnam vet-
erans with such injuries develop epilepsy [22] but these rep-
resent a small proportion of TBI in most societies. There 
have been a large number of studies of patients admitted to 
trauma units with TBI. Inevitably these studies are skewed to 
those with more severe TBI and the cohorts carry a greater 
risk. There have been three larger population-based studies, 
which have looked at injuries ranging from mild to severe [8, 
9, 21] which have been compared, along with smaller studies 
in a meta-analysis [23]. Annegers divided patients’ TBI into 
mild, with less than 30 min post-traumatic amnesia (PTA) 
or loss of consciousness (LOC); moderate with 30 min–24 h 
PTA or LOC and severe with longer PTA or LOC, skull frac-
ture or CT evidence of intracranial injury. The mild group 
carried no increased risk of seizures; the moderate group 
approximately 0.1% annual risk for 20 years and the severe 
group 5% in the first year, a further 5% by 5 years and 17% 
cumulative risk over 20 years from injury. Christensen’s 
study looked at children and young adults over 10 years after 
injury and divided patients into those with mild injury and 
severe injury and used a different analysis. Their mild group 
overlapped the Annegers classification of moderate and gave 
a similar risk, which was highest in the first year and their 
severe group also carried a similar risk to Annegers’ severe 
group. The categorisation in these studies has identified 
a step-shift in risk from mild or moderate cases to severe 
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cases with high risk and begs the question whether there are 
identifiable biomarkers which might increase the granularity 
of risk prediction allowing prediction of risk intermediate 
between those categories. The Mayo clinic is a widely used 
severity classification, which combines different criteria in 
TBI severity assessment for the purpose of acute manage-
ment and rehabilitation rather than epilepsy risk [24].
Yeh et al. used ICD-9-50 definition of concussion to clas-
sify a mild group of TBI, which will again have included 
patients in both Annegers’ mild and moderate groups and 
they defined a further skull fracture group and a severe TBI 
group on the basis imaging evidence of intracranial haem-
orrhage. They compared nearly 20,000 patients attending 
emergency departments from 2000 to 2003 with a head 
injury to more than 500,000 attending for other reasons and 
used a Cox proportional hazards model to identify differ-
ent risk factors for developing epilepsy by 2008. The broad 
headlines were that epilepsy developed in 0.29% of controls; 
1.1% of those with mild TBI; 4.8% of those with skull frac-
tures and 2.2% of those with brain injury. Contusions rep-
resented 59% of the 2528 severe injuries and carried a risk 
of 1.6% of epilepsy, compared with 4.8% for subarachnoid 
haemorrhage; 6.3% for extradural haemorrhage; 7.8% for 
subdural haemorrhage; 10.2% for intracerebral haemorrhage 
and 13.9%, where there was more than one kind of haemor-
rhage. Most likely, some of the subtle contusions that were 
seen on imaging would not have been detected in the case 
ascertainment of the Annegers study from an earlier era of 
imaging, and would have fallen into their mild or moderate 
categories. These data suggest that small contusions should 
not be considered in the same risk category as the other 
forms of haemorrhage or skull fracture and this study help-
fully starts to break down the risk by lesion type.
As well as the nature of the injury, additional risk factors 
for the development of PTE have been identified includ-
ing a prior history of alcohol abuse [23]. An aging brain 
may increase seizure risk [21] as may a family history of 
epilepsy; a genetic predisposition on which TBI is super-
imposed [9]. Early post-traumatic seizures, within the first 
week, are also associated with a significantly greater chance 
of later epilepsy [7, 9]. The brunt of cerebral trauma is well 
known to be carried by the frontal and anterior temporal 
lobes, related to bony structures of the skull but lesion loca-
tion has been inconsistently associated with seizure risk, 
with studies pointing to different parts of the brain as carry-
ing the highest risk [22, 25].
Prevention of seizures and epilepsy
Where patients may be at high risk of developing epilepsy, 
it is tempting to consider medication to prevent seizures. A 
Cochrane review of prophylactic antiepileptic drugs after 
TBI concluded that studies were of poor quality. They found 
that treatment (phenytoin or carbamazepine) may reduce the 
incidence of early post-traumatic seizures but has no impact 
on late seizures or on mortality after TBI [26]. Valproate and 
levetiracetam were also compared to phenytoin and no bene-
fit was found. The Brain Trauma Foundation Guideline does 
not make a recommendation [27]. Prophylaxis for those who 
have not had seizures cannot be recommended without better 
classification of risk. However, a discrete event, bringing a 
patient to medical attention with a significant later epilepsy 
risk, is a relatively unusual situation in clinical epilepsy and 
presents an archetype to consider anti-epileptogenesis in 
humans.
Following injury there are a number of processes, includ-
ing necrosis, microhaemorrhage, axonal injury, apoptosis, 
demyelination, microgliosis, inflammation and oxidative 
stress and later phases of neurodegeneration, regeneration, 
revascularisation and remodelling which may contribute 
to the circuit changes resulting in later epilepsy [28]. The 
challenge is to identify biomarkers for these processes and 
target interventions. Imaging markers such as gradient echo 
MRI for blood products or diffusion tensor MRI for pathway 
remodelling, evidence of thalamic or hippocampal damage 
may help to stratify risk [29]. Genetic markers help stratifi-
cation of the interaction between acquired and constitutional 
risk. There is increasing evidence for degenerative processes 
such as Tau accumulation in post-traumatic epileptogenesis 
[30] or inflammatory changes, for example with IL-1ß levels 
raised in the CSF of patients who later developed epilepsy 
[31]. Neurophysiological changes such as changes in sleep 
spindles or EEG high frequency oscillations identified in 
animal studies may also translate to human epileptogensis 
but studies suffer from the bias of being selectively under-
taken in those at the highest risk [32]. In animal models, 
treatments reducing accumulation of Tau protein; targeting 
iron accumulation; targeting inflammatory pathways and cal-
cium channels involved in apoptosis have all shown some 
success in preventing development of PTE. None is yet of 
proven benefit in humans [33]. Rapamycin, an inhibitor of 
the mTOR pathway has also shown evidence of anti-epilep-
togenesis in animals and has demonstrated efficacy in lesion 
reduction and seizure prevention in humans with tuberous 
sclerosis [34, 35]. It is unlikely to be used widely but repre-
sents a welcome proof of principle of anti-epileptogenesis in 
a field, where there have been many false starts.
Treatment of seizures associated 
with traumatic brain injury
There is one randomised trial of phenytoin v placebo in the 
treatment of early seizures in association with TBI [36]. 
This demonstrated a reduction in early seizures but in the 
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continuation phase, no reduction in the later development of 
epilepsy. Levetiracetam has no benefit compared to pheny-
toin [37]. The Brain Trauma Foundation Guideline supports 
the use of phenytoin for early seizures [27]. A recent survey 
of clinicians in the UK and Ireland suggest that around half 
do not use prophylactic anti-epileptic drugs (AED) but 38% 
use them for a month and 90% were unsure of the correct 
duration of treatment. Levetiracetam was the favoured drug 
[38]. Patients developing seizures are commonly treated 
with medications which are used in acute units in status 
epilepticus, as these can achieve therapeutic doses. Most 
commonly, these are phenytoin or levetiracetam but val-
proate has also been used moderately frequently in status 
epilepticus. Recent evidence suggests that there is little to 
choose between these medications in this context [39, 40].
Patients with PTE will have nearly all suffered significant 
traumatic brain injury and often have cognitive, executive, 
behavioural, emotional and sometimes physical conse-
quences of their injuries as well as epilepsy. There is a sig-
nificant associated psychosocial morbidity and a mortality as 
well as associated drug use or alcoholism which profoundly 
affect quality of life but also have an impact on epilepsy 
treatment [41–44]. These aspects need to be considered in 
management but are beyond the remit of this article. Equally, 
late mortality may be significantly higher in those with epi-
lepsy than in those with otherwise similar injuries and no 
epilepsy [45].
In terms of epilepsy classification, PTE is a syndrome 
with generalised and focal seizures and a structural cause 
[46], previously known as focal, remote symptomatic epi-
lepsy. Clinical trials of AED in this group do not differenti-
ate between aetiologies and there are no trials of medication 
specifically for patients with PTE. The considerations are, 
therefore, to achieve seizure control, if possible and avoid 
specific comorbidities that may be associated with TBI. 
Especially if behavioural or mood issues are of particular 
concern, then the authors’ first choice for long term treat-
ment would be lamotrigine, carbamazepine, oxcarbazepine 
or lacosamide. Lamotrigine may be associated with head-
aches and sleep disturbance, which may affect those with 
TBI and carbamazepine and oxcarbazepine may exacerbate 
hyponatraemia in those with inappropriate ADH secretion. 
Whilst irritability is more common with levetiracetam it 
does not preclude its use with appropriate monitoring and 
brivaracetam may be useful in those who suffer this com-
plication but whose epilepsy responds well to levetiracetam.
Approximately one-third of epilepsy will prove refractory 
to medication and it is not clear if there is any systematic 
difference in post-traumatic cases compared to other causes. 
In this group epilepsy surgery may be considered. Since 
Horsley [4] it has been known that this can be a successful 
treatment for PTE. Modern studies confirm that it may be 
successful in those appropriately selected, where the injury 
is either unifocal, or if multifocal, that investigation confirms 
that only one region is epileptogenic and where the patient 
is able to cope with the neuropsychological consequences of 
resection [47]. Another, larger study also had good outcomes 
but probably included a significant number of non-traumatic 
cases, since their definition of trauma included all injuries 
with PTA of > 30 min and 44% had mesial temporal scle-
rosis, not generally associated with traumatic injury [48] 
Vagus nerve stimulation has been suggested to work better 
for PTE with 73% seizure reduction at 24 months compared 
to 57% for non-TBI related epilepsy [49].
Head injury and dissociative seizures
Clinicians may be tempted to assume that seizures occur-
ring following head injury are epileptic. However, TBI is 
also associated with dissociative seizures (previously called 
psychogenic non-epileptic seizures). US epilepsy centres 
identified this association in the 1990’s, and a recent review 
of 17 subsequent studies corroborated this link in adult 
and paediatric populations [50–52]. Dissociative seizures 
superficially resemble epileptic seizures, and 1 in 5 patients 
referred to epilepsy clinics with a prior diagnosis of refrac-
tory PTE actually have dissociative seizures [53, 54]. Where 
an injury has been mild and the a priori risk of epilepsy is 
very low, post-traumatic seizures are more likely to be dis-
sociative than epileptic [50, 51]. Most reports point to onset 
of nearly all dissociative seizures (81–89%) within a year 
of TBI, whereas epilepsy risk declines more gradually in 
the years following trauma [8]. Patients with dissociative 
seizures also show a lack of response to anti-epileptic drugs 
(AEDs), which could be perceived as a ‘red flag’ for their 
diagnosis [55]. AEDs have additionally been observed to 
worsen outcomes in some patients with dissociative seizures 
[55]. Association with post-traumatic stress disorder (PTSD) 
and other psychiatric comorbidities further delineates post-
traumatic dissociative seizures from epileptic seizures. For 
example, 57% of US veterans with post-traumatic disso-
ciative seizures also have PTSD, compared with an over-
all PTSD prevalence of less than 10% observed in another 
cohort of veterans [57, 58]. A higher rate of other psychiat-
ric comorbidities than in PTE, significantly increases illness 
burden for many patients.
Overall, significantly more women than men (3:1) are 
affected by dissociative seizures, compared to a male pre-
ponderance for epileptic seizures [59]. This may be due to 
greater female vulnerability to any number of predisposing 
factors [60]. The majority of patients developing post-trau-
matic dissociative seizures are female [51]. Other recognised 
associations of dissociative seizures, such as physical and 
sexual abuse, may need to be sought for a holistic assess-
ment [61].
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Psychological therapies are the mainstay of dissocia-
tive seizure management, giving significant symptomatic 
improvement but relatively few patients with dissociative 
seizures can expect to become seizure-free [62]. Diagnos-
tic delay is greater than for epilepsy and is a factor which 
may adversely affect prognosis [56]. Increased awareness 
of the distinguishing features of post-traumatic dissociative 
seizures may help to tease these cases apart from their epi-
leptic counterparts enabling appropriate management for the 
best chance of seizure reduction and improved quality of life.
Summary
Seizures are a common complication of moderate to severe 
head injury, which may arise over many years. Intracerebral 
haemorrhage but not small contusions, carry a high risk 
and further work needs to be done to stratify cases. We are 
starting to understand some of the mechanisms underlying 
epileptogenesis, but this has not yet translated into preventa-
tive treatments. Our current information is not sufficiently 
granular to separate treatment of PTE from other forms of 
focal epilepsy but medication, respective surgery and VNS 
may all be useful. Dissociative seizures are common and 
require a high index of suspicion after mild injury.
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